BAD HOMBURG (dpa-AFX) - Dialysis specialist Fresenius Medical Care (FMC) is launching another share buyback program. Over the next twelve months, the DAX-listed group intends to acquire its own shares in several tranches for a total volume of approximately one billion euros, as announced in Bad Homburg on Tuesday. The buyback is set to commence in the short term. The group further stated that the shares are primarily intended to be cancelled, though a significantly smaller portion could also be used for allocations under performance-based compensation plans. The stock turned positive on the news and was last trading up around 0.6 percent.

Share buybacks are a popular tool for supporting stock prices, as the additional demand can provide stability. Furthermore, with fewer shares in circulation, the earnings per share (EPS) - a metric closely watched by analysts - automatically increases. FMC shares have been on a downward trend for some time, losing around 7 percent in value since the turn of the year alone.

The blood purification specialist only recently completed a share buyback program: between August 2025 and April 2026, the Bad Homburg-based company had also acquired its own shares worth one billion euros./tav/stk